HSD3B1 and metastatic neoplasm: The missense-encoding adrenal-permissive HSD3B1 allele, which is present in about half of all men, enables prostate cancer intratumoral androgen biosynthesis from nongonadal precursor steroids, thus linking this genetically driven mechanism to poorer clinical outcomes across multiple cohorts and settings, including localized and metastatic disease.